全文获取类型
收费全文 | 1811819篇 |
免费 | 137117篇 |
国内免费 | 10266篇 |
专业分类
耳鼻咽喉 | 22855篇 |
儿科学 | 57442篇 |
妇产科学 | 48757篇 |
基础医学 | 253285篇 |
口腔科学 | 51208篇 |
临床医学 | 166512篇 |
内科学 | 351612篇 |
皮肤病学 | 40124篇 |
神经病学 | 136907篇 |
特种医学 | 67724篇 |
外国民族医学 | 282篇 |
外科学 | 269244篇 |
综合类 | 57930篇 |
现状与发展 | 24篇 |
一般理论 | 548篇 |
预防医学 | 133199篇 |
眼科学 | 43463篇 |
药学 | 136269篇 |
121篇 | |
中国医学 | 10921篇 |
肿瘤学 | 110775篇 |
出版年
2021年 | 18035篇 |
2019年 | 17033篇 |
2018年 | 23725篇 |
2017年 | 18750篇 |
2016年 | 19782篇 |
2015年 | 23998篇 |
2014年 | 32642篇 |
2013年 | 44552篇 |
2012年 | 62359篇 |
2011年 | 65811篇 |
2010年 | 40026篇 |
2009年 | 36622篇 |
2008年 | 58943篇 |
2007年 | 62165篇 |
2006年 | 62258篇 |
2005年 | 58927篇 |
2004年 | 55317篇 |
2003年 | 52298篇 |
2002年 | 49778篇 |
2001年 | 94053篇 |
2000年 | 95691篇 |
1999年 | 78999篇 |
1998年 | 20925篇 |
1997年 | 18400篇 |
1996年 | 18302篇 |
1995年 | 17616篇 |
1994年 | 16107篇 |
1993年 | 14527篇 |
1992年 | 57977篇 |
1991年 | 55786篇 |
1990年 | 53441篇 |
1989年 | 51135篇 |
1988年 | 46493篇 |
1987年 | 45230篇 |
1986年 | 42463篇 |
1985年 | 40174篇 |
1984年 | 29458篇 |
1983年 | 25009篇 |
1982年 | 13962篇 |
1979年 | 25606篇 |
1978年 | 17632篇 |
1977年 | 14950篇 |
1976年 | 13910篇 |
1975年 | 14590篇 |
1974年 | 17681篇 |
1973年 | 16984篇 |
1972年 | 15722篇 |
1971年 | 14481篇 |
1970年 | 13455篇 |
1969年 | 12536篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
2.
Kienbaum Peter Schaefer Maximilian S. Weibel Stephanie Schlesinger Tobias Meybohm Patrick Eberhart Leopold H. Kranke Peter 《Der Anaesthesist》2022,71(2):123-128
Die Anaesthesiologie - Auch wenn für Anästhesiologen über Jahrzehnte die Prophylaxe und Therapie postoperativer Schmerzen im Rahmen des postoperativen Patientenkomforts an vorderster... 相似文献
3.
4.
5.
6.
7.
8.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
9.
Zeyu Li Erwei Hao Rui Cao Si Lin Linghui Zou Tianyan Huang Zhengcai Du Xiaotao Hou Jiagang Deng 《中草药(英文版)》2022,14(4):479-493
Zedoary tumeric (Curcumae Rhizoma, Ezhu in Chinese) has a long history of application and has great potential in the treatment of liver cancer. The anti liver cancer effect of zedoary tumeric depends on the combined action of multiple pharmacodynamic substances. In order to clarify the specific mechanism of zedoary tumeric against liver cancer, this paper first analyzes the mechanism of its single pharmacodynamic substance against liver cancer, and then verifies the joint anti liver cancer mechanism of its "pharmacodynamic group". By searching the research on the anti hepatoma effect of active components of zedoary tumeric in recent years, we found that pharmacodynamic substances, including curcumol, zedoarondiol, curcumenol, curzerenone, curdione, curcumin, germacrone, β-elemene, can act on multi-target and multi-channel to play an anti hepatoma role. For example, curcumin can regulate miR, GLO1, CD133, VEGF, YAP, LIN28B, GPR81, HCAR-1, P53 and PI3K/Akt/mTOR, HSP70/TLR4 and NF-κB. Wnt/TGF/EMT, Nrf2/Keap1, JAK/STAT and other pathways play an anti hepatoma role. Network pharmacological analysis showed that the core targets of the "pharmacodynamic group" for anti-life cancer are AKT1, EGFR, MAPK8, etc, and the core pathways are neuroactive live receiver interaction, nitrogen metabolism, HIF-1 signaling pathway, etc. At the same time, by comparing and analyzing the relationship between the specific mechanisms of pharmacodynamic substance and "pharmacodynamic group", it is found that they have great reference significance in target, pathway, biological function, determination of core pharmacodynamic components, formation of core target protein interaction, in-depth research of single pharmacodynamic substance, increasing curative effect and so on. By analyzing the internal mechanism of zedoary tumeric pharmacodynamic substance and "pharmacodynamic group" in the treatment of liver cancer, this paper intends to provide some ideas and references for the deeper pharmacological research of zedoary tumeric and the relationship between pharmacodynamic substance and "pharmacodynamic group". 相似文献
10.